Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement

Nature Reviews Clinical Oncology 2026 Open access

Read full text
Authors: Josep M. Llovet, Ezequiel Mauro, Lorenza Rimassa, Vincenzo Mazzaferro, Matthias Pinter, Robin Kate Kelley, Stephen L. Chan, Laura Kulik, Anjana Pillai, Lewis R. Roberts, Bruno Sangro, Teresa Casanovas
+6 more David E. Kaplan, Arndt Vogel, Mark Yarchoan, Richard S. Finn, Tim Meyer, Amit G. Singal
DOI: 10.1038/s41571-026-01160-z
Cited by: 5
References: 176

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Liver physiology and pathology Cancer Mechanisms and Therapy

Publication details

Journal / source
Nature Reviews Clinical Oncology
Publisher
Springer Science and Business Media LLC
Volume
23
Issue
8
Pages
619–647
Publication date
10 June 2026
Language
EN